{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:35:00Z","timestamp":1789842900713,"version":"4.0.1"},"reference-count":30,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2024,12,17]]},"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:p>Nephrotic syndrome is characterised by heavy proteinuria secondary to glomerular injury. It is an uncommon but serious complication of allogeneic haematopoietic stem cell transplant (HSCT), but rarely reported after autologous HSCT. Here, we report the case of a man in his mid-20s who presented with significant peripheral oedema 2\u2009months after autologous HSCT for Hodgkin lymphoma. Investigations demonstrated nephrotic range proteinuria and hypoalbuminaemia. Renal biopsy demonstrated minimal change disease. Initial treatment with glucocorticoids was complicated by toxicity without remission. However, the clinical and biochemical resolution of his nephrotic syndrome promptly followed administration of rituximab. This case highlights nephrotic syndrome as a complication after autologous HSCT and suggests potential effectiveness of rituximab in minimal change disease in the presence of steroid toxicity or other contraindications.<\/jats:p>","DOI":"10.1136\/bcr-2023-259306","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T21:20:22Z","timestamp":1737667222000},"page":"e259306","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Minimal change disease following autologous stem cell transplant for Hodgkin lymphoma"],"prefix":"10.1136","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8403-2468","authenticated-orcid":false,"given":"Patrick","family":"Leung","sequence":"first","affiliation":[{"name":"Department of Haematology, Northern Health, Epping, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Pianta","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Northern Health, Epping, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Langsford","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Northern Health, Epping, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui Sien","family":"Tay","sequence":"additional","affiliation":[{"name":"Department of Anatomical Pathology, Alfred Health, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Cooke","sequence":"additional","affiliation":[{"name":"Department of Haematology, Northern Health, Epping, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,1,23]]},"reference":[{"key":"2025082711554039000_18.1.e259306.1","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.hoc.2009.04.013","article-title":"Hodgkin lymphoma","volume":"23","author":"Schnitzer","year":"2009","journal-title":"Hematol Oncol Clin North Am"},{"key":"2025082711554039000_18.1.e259306.2","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/725219","article-title":"Incidence patterns and outcomes for hodgkin lymphoma patients in the United States","volume":"2011","author":"Shenoy","year":"2011","journal-title":"Adv Hematol"},{"key":"2025082711554039000_18.1.e259306.3","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5000341"},{"key":"2025082711554039000_18.1.e259306.4","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfq645"},{"key":"2025082711554039000_18.1.e259306.5","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(86)90049-5"},{"key":"2025082711554039000_18.1.e259306.6","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1093\/ckj\/sfac264","article-title":"Clinico-pathological correlations and outcomes of de novo glomerular diseases in patients after haematopoietic stem cell transplantation","volume":"16","author":"Yap","year":"2023","journal-title":"Clin Kidney J"},{"key":"2025082711554039000_18.1.e259306.7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05728.x"},{"key":"2025082711554039000_18.1.e259306.8","first-page":"639","article-title":"Murine chronic graft-versus-host disease as a model for lupus nephritis","volume":"130","author":"Bruijn","year":"1988","journal-title":"Am J Pathol"},{"key":"2025082711554039000_18.1.e259306.9","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfv036"},{"key":"2025082711554039000_18.1.e259306.10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12882-018-0855-z","article-title":"Membranous nephropathy succeeding autologous hematopoietic stem cell transplant: a case report","volume":"19","author":"Mrabet","year":"2018","journal-title":"BMC Nephrol"},{"key":"2025082711554039000_18.1.e259306.11","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/j.ekir.2021.05.033","article-title":"Membranous Glomerulopathy After Autologous Hematopoietic Stem Cell Transplant in a Patient With Multiple Myeloma","volume":"6","author":"Rodr\u00edguez Feria","year":"2021","journal-title":"Kidney Int Rep"},{"key":"2025082711554039000_18.1.e259306.12","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0900225"},{"key":"2025082711554039000_18.1.e259306.13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1752-8062.2009.00128.x"},{"key":"2025082711554039000_18.1.e259306.14","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.7.4125"},{"key":"2025082711554039000_18.1.e259306.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(04)00335-6"},{"key":"2025082711554039000_18.1.e259306.16","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1313654110"},{"key":"2025082711554039000_18.1.e259306.17","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200027","article-title":"B-Cell Reconstitution After Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis","volume":"9","author":"von Niederh\u00e4usern","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2025082711554039000_18.1.e259306.18","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12985"},{"key":"2025082711554039000_18.1.e259306.19","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.736137","article-title":"CD4+ T Cell Dependent B Cell Recovery and Function After Autologous Hematopoietic Stem Cell Transplantation","volume":"12","author":"Heck","year":"2021","journal-title":"Front Immunol"},{"key":"2025082711554039000_18.1.e259306.20","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jamaneurol.2017.0676","article-title":"Interpreting Lymphocyte Reconstitution Data From the Pivotal Phase 3 Trials of Alemtuzumab","volume":"74","author":"Baker","year":"2017","journal-title":"JAMA Neurol"},{"key":"2025082711554039000_18.1.e259306.21","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1038\/s41409-021-01277-y","article-title":"New autoimmune diseases after autologous hematopoietic stem cell transplantation for multiple sclerosis","volume":"56","author":"Burt","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"2025082711554039000_18.1.e259306.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.05.021"},{"key":"2025082711554039000_18.1.e259306.23","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfu209"},{"key":"2025082711554039000_18.1.e259306.24","doi-asserted-by":"crossref","first-page":"28799","DOI":"10.18632\/oncotarget.25612","article-title":"Rituximab as a front-line therapy for adult-onset minimal change disease with nephrotic syndrome","volume":"9","author":"Fenoglio","year":"2018","journal-title":"Oncotarget"},{"key":"2025082711554039000_18.1.e259306.25","doi-asserted-by":"publisher","DOI":"10.1186\/ar3541"},{"key":"2025082711554039000_18.1.e259306.26","doi-asserted-by":"crossref","unstructured":"Fragiotta S , Mangino G , Iuliano M , et al . Role of CD 20+ T cells and related cytokines in mediating retinal microvascular changes and ocular complications in chronic-plaque type psoriasis. Cytokine 2020;136. doi:10.1016\/j.cyto.2020.155253","DOI":"10.1016\/j.cyto.2020.155253"},{"key":"2025082711554039000_18.1.e259306.27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.586012","article-title":"Rituximab Induces Complete Remission of Proteinuria in a Patient With Minimal Change Disease and No Detectable B Cells","volume":"11","author":"Webend\u00f6rfer","year":"2020","journal-title":"Front Immunol"},{"key":"2025082711554039000_18.1.e259306.28","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abi4632","article-title":"Proinflammatory CD20+ T cells contribute to CNS-directed autoimmunity","volume":"14","author":"Ochs","year":"2022","journal-title":"Sci Transl Med"},{"key":"2025082711554039000_18.1.e259306.29","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfaa279"},{"key":"2025082711554039000_18.1.e259306.30","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2021060794"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2023-259306","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T18:55:50Z","timestamp":1756320950000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2023-259306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,23]]},"published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1136\/bcr-2023-259306"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2023-259306","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]}}}